To study the characteristics and outcomes of cancer patients with coronavirus (Covid 19) admitted to the intensive care unit in a Cancer Centre
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/06/034301
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All adult patients >18 years diagnosed with Covid-19 admitted to the Intensive Care unit in TMH
Exclusion Criteria
Post Bone Marrow transplant
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality in the ICU for cancer patients with covid-19Timepoint: At 30 day
- Secondary Outcome Measures
Name Time Method In-hospital mortality and 30-day mortality for cancer patients with covid-19Timepoint: At 30 day <br/ ><br>